The Dow Jones Industrial Average will lose more than 240 points today as investors fret over the latest round of U.S. tariffs on China.
While markets continue to monitor earnings and the Trump administration's trade policies, I expect a lot of chatter about tariffs and negotiations.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
These small-cap stocks have yet to be fully discovered by the rest of the market.
Some small caps are already climbing this year, but overall, this class of stocks is looking poised for a run much higher.
by Tim Melvin
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
If you own Boeing Co., the last month has clearly been an "intestinally challenging" ride: 10% straight down after two of the company's new 747 Max 8 aircraft crashed in Indonesia and Ethiopia. It's down around 16% from its all-time highs…
The Max 8 fleet is grounded for now; Garuda Indonesia is the first major carrier to cancel its Max 8 orders – $6.9 billion worth – and there's no telling who could follow. It may be a good long while before they can start flying, let alone selling, these planes again. So obviously, Boeing has taken a reputational hit as well.
Unsurprisingly, I've listened to a couple of Boeing investors lamenting their losses in recent weeks.
To them, I'd say: Look, I have no idea how all the investigations will end, or when they will end, but I suspect Boeing survives just fine.
And I have one solid piece of advice for them – and you – and anyone who's ever watched one of their favorite, hard-won stocks tank…
Relax!
There's more than a little upside in doing just that...
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Axovant Sciences just topped our list of the 10 top penny stocks to watch this week thanks to its 150% gain.
Fortunately, we've found a way to find stocks with even bigger profit potential.
Last Thursday (June 7), shares of Axovant jumped 44% on news that the company will license its experimental treatment for Parkinson's disease.
Axovant finished the week at $4.81, a gain of 150% on Monday's share price.
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The Dow Jones Industrial Average today is falling as the European Central Bank decided to keep interest rates the same.
Investors are still concerned that central banks are running out of ideas to stimulate the economy.
Start the conversation